Joel Russell
About Joel Russell
Joel Russell is a Senior HEOR Manager at Bristol Myers Squibb in London, with a background in health economics and various roles in research and academia.
Company
Joel Russell is currently working at Bristol Myers Squibb. Founded on the principles of innovation and patient-focused care, Bristol Myers Squibb is a global biopharmaceutical company. Joel's role as Senior HEOR Manager places him within the important sectors of health economics and outcomes research, particularly focused on managing HTA submissions in haematology and oncology for the UK and Ireland.
Title
Joel Russell holds the title of Senior HEOR Manager at Bristol Myers Squibb, a role he has been in since September 2021. This position entails a significant focus on health economics and outcomes research, especially in the haematology and oncology fields. His responsibilities include managing HTA submissions to ensure market access and reimbursement strategies align with the company's objectives.
Education and Expertise
Joel Russell's educational background includes a Master of Science (MSc) in Health Economics from the University of York, completed in 2018, and a Bachelor of Science (BSc) in Economics from the University of East Anglia, completed in 2017. His academic expertise in health economics and general economics underpins his professional roles, equipping him with the necessary skills to navigate the complex landscape of health economics and outcomes research.
Background
Joel Russell has a diversified background in health economics and related fields, having worked in varied roles across multiple respected institutions. Before his current position, he served as a Technical Lead at NICE, as a Research Consultant at York Health Economics Consortium, and as a Module Tutor at the University of York. His previous experiences also include research and analytical roles at Memorial Sloan Kettering Cancer Center, University of East Anglia, and working under Professor Andrew Briggs.
Achievements
Among Joel Russell's notable professional milestones is his management of HTA submissions in haematology and oncology for the UK & Ireland at Bristol Myers Squibb. This role highlights his capacity to handle significant project responsibilities in health economics. Additionally, his tenure at NICE, where he served as a Technical Lead, further underscores his proficiency in guiding health economics projects critical to national health guidelines.